Drugs / Concentrated Bone Marrow Aspirate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT03271229 Comparator | Sep 2019 → Jan 2021 | osteoarthritis, knee | Mayo Clinic | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Concentrated Bone Marrow Aspirate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03271229 ↗ |
| Known as | BMAC | “Concentrated Bone Marrow Aspirate (BMAC)” NCT03271229 ↗ |
| Modality | Cell therapy | “BMAC stem cells” NCT03271229 ↗ |
| Route | Other | “Concentrated Bone Marrow Aspirate (BMAC) injections into symptomatic knee” NCT03271229 ↗ |